↓ Skip to main content

Newer generation antidepressants for depressive disorders in children and adolescents

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
policy
2 policy sources
twitter
15 tweeters
facebook
1 Facebook page
wikipedia
4 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
149 Dimensions

Readers on

mendeley
57 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Newer generation antidepressants for depressive disorders in children and adolescents
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd004851.pub3
Pubmed ID
Authors

Sarah E Hetrick, Joanne E McKenzie, Georgina R Cox, Magenta B Simmons, Sally N Merry

Abstract

Depressive disorders are common in young people and are associated with significant negative impacts. Newer generation antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are often used, however evidence of their effectiveness in children and adolescents is not clear. Furthermore, there have been warnings against their use in this population due to concerns about increased risk of suicidal ideation and behaviour.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 4%
Other 1 2%
Student > Postgraduate 1 2%
Researcher 1 2%
Unknown 52 91%
Readers by discipline Count As %
Nursing and Health Professions 2 4%
Unspecified 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Medicine and Dentistry 1 2%
Unknown 52 91%

Attention Score in Context

This research output has an Altmetric Attention Score of 61. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2019.
All research outputs
#280,264
of 13,504,032 outputs
Outputs from Cochrane database of systematic reviews
#730
of 10,618 outputs
Outputs of similar age
#1,841
of 117,126 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 100 outputs
Altmetric has tracked 13,504,032 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,618 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 117,126 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.